← Eichor
Condition: Von Willebrand Diseases Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Von Willebrand Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Severe Congenital Hemostatic Defects, Cerebral MIcrobleeds and COGnition
Phase N/A · 1 location(s) · University Hospital, Lille · NCT06090201The Severe Von Willebrand Disease (sVWD) Patient Registry
Phase N/A · 1 location(s) · VWD Connect Foundation · NCT05437536Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07358013Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Phase 1/Phase 2 · 25 location(s) · Vega Therapeutics, Inc · NCT05776069World Bleeding Disorders Registry
Phase N/A · 1 location(s) · World Federation of Hemophilia · NCT03327779Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angiop
Phase 3 · 1 location(s) · Cardiocentro Ticino · NCT07582835A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Phase N/A · 17 location(s) · Hemab ApS · NCT06610201An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)
Phase N/A · 1 location(s) · Takeda · NCT07404644Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease
Phase 2 · 1 location(s) · Medical University of Vienna · NCT07273721Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease
NA · 17 location(s) · University Hospital, Lille · NCT06651255Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
NA · 1 location(s) · University Hospital, Lille · NCT04119908Von Willebrand Factor Point-of-care Testing to Improve Minimally Invasive TAVI Outcomes
NA · 9 location(s) · University Hospital, Lille · NCT03728049Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Phase 3 · 14 location(s) · Vega Therapeutics, Inc · NCT07115004Exploration of Systemic and Portal Hemostasis in Patients Undergoing Transjugular Intrahepatic Portosystemic Shunt Place
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07439939A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Phase 3 · 21 location(s) · Takeda · NCT05582993A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
Phase 3 · 7 location(s) · Takeda · NCT07129343A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD
Phase 3 · 1 location(s) · Unity Health Toronto · NCT06205095Von Willebrand Factor in Pregnancy (VIP) Study
Phase N/A · 11 location(s) · University of Washington · NCT04146376Effects of Bothrops Spp. Snake Envenomation on Willebrand Factor Activity in Martinique and French Guiana
Phase N/A · 1 location(s) · University Hospital Center of Martinique · NCT06304714A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease
Phase 3 · 28 location(s) · Hoffmann-La Roche · NCT06998524A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · 25 location(s) · Hemab ApS · NCT06754852Genotype and Phenotype Correlation in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome)
Phase N/A · 7 location(s) · Insel Gruppe AG, University Hospital Bern · NCT01257269Recombinant vWF Concentrate and ECMO
Phase 1 · 1 location(s) · University of Virginia · NCT06118372ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Phase N/A · 71 location(s) · American Thrombosis and Hemostasis Network · NCT04398628External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis
Phase N/A · 16 location(s) · Instituto de Investigación Sanitaria de la Fundación Jiménez · NCT07418099Heavy Menstrual Bleeding Progestin Treatment in Bleeding Disorders Study
Phase N/A · 9 location(s) · Oregon Health and Science University · NCT05916469ATHNdataset Registry
Phase N/A · 1 location(s) · American Thrombosis and Hemostasis Network · NCT06820515Blood Clotting Markers and Heart Ultrasound in People With Device-Detected Atrial Fibrillation
Phase N/A · 1 location(s) · Andreas Sjøholm-Christensen · NCT07713615Cardiovascular and Venous Thromboembolism Disease in Patients with Von Willebrand Disease in the French West
Phase N/A · 6 location(s) · University Hospital, Brest · NCT05773638Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
Phase 1 · 12 location(s) · Bleeding and Clotting Disorders Institute Peoria, Illinois · NCT05500807
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.